Profile data is unavailable for this security.
About the company
GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. It is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The Company is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.
- Revenue in USD (TTM)0.00
- Net income in USD-7.10m
- Incorporated2010
- Employees6.00
- LocationGlucoTrack Inc301 Rte 17 North, Ste. 800RUTHERFORD 07070United StatesUSA
- Phone+1 (201) 842-7715
- Fax+1 (302) 655-5049
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pieris Pharmaceuticals Inc | 42.81m | -24.54m | 13.79m | 46.00 | -- | 0.5153 | -- | 0.3221 | -22.94 | -22.94 | 38.03 | 21.64 | 0.6382 | -- | 13.42 | 930,652.20 | -36.58 | -28.41 | -57.30 | -39.69 | -- | -- | -57.33 | -94.61 | -- | -- | 0.00 | -- | 65.28 | 8.03 | 26.25 | -- | -36.82 | -- |
Coeptis Therapeutics Holdings Inc | 0.00 | -21.27m | 13.83m | 5.00 | -- | 3.14 | -- | -- | -0.8922 | -0.8922 | 0.00 | 0.1221 | 0.00 | -- | -- | 0.00 | -266.05 | -36.90 | -392.90 | -37.81 | -- | -- | -- | -- | -- | -- | 0.2068 | -- | -- | -- | 43.40 | -- | -- | -- |
Vicapsys Life Sciences Inc | 0.00 | -1.08m | 14.24m | 2.00 | -- | -- | -- | -- | -0.0327 | -0.0327 | 0.00 | -0.0416 | 0.00 | -- | -- | 0.00 | -364.66 | -- | -- | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- | -- | -317.25 | -- | -- | -- |
Tonix Pharmaceuticals Holding Corp | 7.77m | -116.66m | 14.51m | 103.00 | -- | 0.0954 | -- | 1.87 | -8.62 | -8.62 | 0.4572 | 1.80 | 0.0409 | -- | -- | 75,417.48 | -61.38 | -59.46 | -68.01 | -65.92 | 38.97 | -- | -1,501.78 | -5,126.73 | 1.81 | -- | 0.0779 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
Edesa Biotech Inc | 0.00 | -7.72m | 14.83m | 16.00 | -- | 2.50 | -- | -- | -2.60 | -2.60 | 0.00 | 1.85 | 0.00 | -- | -- | 0.00 | -79.13 | -- | -95.05 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
Mannatech Inc | 131.96m | -2.24m | 14.98m | 213.00 | -- | 1.41 | -- | 0.1136 | -1.21 | -1.21 | 70.53 | 5.64 | 2.92 | 1.99 | 854.08 | 619,507.10 | -4.96 | 4.39 | -12.90 | 9.16 | 77.95 | 77.87 | -1.70 | 1.72 | 0.5093 | -5.81 | 0.1226 | 88.33 | -3.83 | -5.33 | 50.13 | -- | -20.38 | -- |
GlucoTrack Inc | 0.00 | -7.10m | 14.99m | 6.00 | -- | 3.66 | -- | -- | -0.3394 | -0.3394 | 0.00 | 0.153 | 0.00 | -- | -- | 0.00 | -193.30 | -94.01 | -294.60 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | 0.0578 | -- | -- | -- | -60.02 | -- | -- | -- |
Oncotelic Therapeutics Inc | 70.00k | -7.90m | 15.25m | 22.00 | -- | 1.26 | -- | 217.84 | -0.02 | -0.02 | 0.0002 | 0.0304 | 0.0021 | -- | 3.61 | 3,181.82 | -24.82 | -25.03 | -49.08 | -48.76 | -- | -- | -11,722.94 | -1,692.93 | -- | -0.4788 | 0.5199 | -- | -- | -- | -255.12 | -- | -- | -- |
Allied Corp | 21.51k | -9.00m | 15.59m | -- | -- | -- | -- | 724.63 | -0.0915 | -0.0915 | 0.0002 | -0.0711 | 0.0051 | 1.65 | 0.1441 | -- | -214.39 | -- | -- | -- | -6,919.57 | -- | -41,861.41 | -- | 0.0333 | -31.86 | -- | -- | -56.46 | -- | 31.30 | -- | -- | -- |
Curative Biotechnology Inc | 0.00 | -6.02m | 15.72m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
Ibio Inc | 50.00k | -20.77m | 15.93m | 26.00 | -- | 0.6525 | -- | 318.62 | -21.91 | -27.30 | 0.0437 | 2.84 | 0.0012 | -- | 0.0129 | 1,923.08 | -48.41 | -28.09 | -113.84 | -32.63 | -- | -- | -41,546.00 | -1,467.30 | -- | -518.33 | 0.5942 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
Trinity Biotech plc (ADR) | 56.83m | -36.87m | 16.09m | 380.00 | -- | -- | -- | 0.2831 | -4.82 | -3.14 | 7.42 | -15.67 | 0.7501 | 1.76 | 3.83 | 149,557.90 | -48.66 | -20.30 | -61.88 | -29.54 | 34.22 | 39.92 | -64.87 | -29.86 | 1.27 | -1.61 | 1.55 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
Holder | Shares | % Held |
---|---|---|
Sabby Management LLCas of 31 Dec 2023 | 428.91k | 1.75% |
Alerus Financial, NA (Private Banking)as of 31 Dec 2023 | 69.28k | 0.28% |
Citadel Securities LLCas of 31 Dec 2023 | 39.18k | 0.16% |
Boston Financial Management LLCas of 31 Dec 2023 | 26.37k | 0.11% |
Accurate Wealth Management LLCas of 31 Mar 2024 | 22.10k | 0.09% |
Virtu Americas LLCas of 31 Dec 2023 | 18.91k | 0.08% |
Two Sigma Securities LLCas of 31 Dec 2023 | 13.32k | 0.05% |
UBS Securities LLCas of 31 Dec 2023 | 4.80k | 0.02% |
Warberg Asset Management LLCas of 31 Dec 2023 | 0.00 | 0.00% |